4r1v
From Proteopedia
(Difference between revisions)
| Line 6: | Line 6: | ||
Description: Identification and optimization of pyridazinones as potent and selective c-Met kinase inhibitors | Description: Identification and optimization of pyridazinones as potent and selective c-Met kinase inhibitors | ||
| + | [[Category: Unreleased Structures]] | ||
| + | [[Category: Meyring, M]] | ||
| + | [[Category: Graedler, U]] | ||
| + | [[Category: Stieber, F]] | ||
| + | [[Category: Knuehl, C]] | ||
| + | [[Category: Fittschen, C]] | ||
| + | [[Category: Schadt, O]] | ||
| + | [[Category: Friese-Hamim, M]] | ||
| + | [[Category: Dorsch, D]] | ||
| + | [[Category: Blaukat, A]] | ||
| + | [[Category: Bladt, F]] | ||
Revision as of 16:23, 24 December 2014
Unreleased structure
The entry 4r1v is ON HOLD until Paper Publication
Authors: Blaukat, A., Bladt, F., Friese-Hamim, M., Knuehl, C., Fittschen, C., Graedler, U., Meyring, M., Dorsch, D., Stieber, F., Schadt, O.
Description: Identification and optimization of pyridazinones as potent and selective c-Met kinase inhibitors
